Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life (2026) Wurschi GW, Hinz A, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, et al. Journal article Real-world progression-free survival and overall survival in patients with HR+/HER2− advanced breast cancer treated in first-line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study (2026) Fasching P, Brucker C, Decker T, Engel A, Göhler T, Jackisch C, Janssen J, et al. Journal article Integrin β6 expression in colorectal cancer cells promotes liver metastasis through enhanced adhesion to endothelial fibronectin (2025) Van Passen C, Krug J, Weiß L, Mohamed Abdou M, Tripal P, Schmid B, Krüger R, et al. Journal article SOX10, MITF, and microRNAs: Decoding their interplay in regulating melanoma plasticity (2025) Lai X, Luan C, Zhang Z, Wessely A, Heppt M, Berking C, Vera J Journal article, Review article Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD? (2025) Schubart C, Tögel L, Carta MG, Hetzner P, Helbig L, Zaglas C, Ziegler M, et al. Journal article Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma—Real-world data from the German research platform CARAT (2025) Goebell P, Bögemann M, Nusch A, Grünwald V, Müller L, von der Heyde E, Martens UM, et al. Journal article Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial (2025) Beierlein M, Häberle L, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, et al. Journal article Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune-related adverse events during treatment with immune checkpoint inhibitors (2025) Schmitt C, Müller KJ, Tiedt S, Kramer N, Manger I, Knauss S, Müller-Jensen L, et al. Journal article Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study (2024) Lüftner D, Schuetz F, Schneeweiss A, Hartkopf A, Bloch W, Decker T, Uleer C, et al. Journal article Germline variants of homology-directed repair or mismatch repair genes in cervical cancer (2024) Kokemüller L, Ramachandran D, Schürmann P, Geffers R, Jentschke M, Böhmer G, Strauß HG, et al. Journal article